• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
Grand Rounds
CMECNE

Which Surgeries are Most Likely to Lead to Urinary Tract Injury?

image_pdfFavoriteLoadingFavorite

Learning Objectives and CME/Disclosure Information

This activity is intended for healthcare providers delivering care to women and their families.

After completing this activity, the participant should be better able to:

1. State the complication rate for ureteric and bladder injuries during gynecologic laparoscopy for benign indications
2. Discuss the authors’ conclusion regarding the use of routine cystoscopy as part of gynecologic laparoscopic procedures

Estimated time to complete activity: 0.25 hours

Faculty:

Susan J. Gross, MD, FRCSC, FACOG, FACMG
President and CEO, The ObG Project

Disclosure of Conflicts of Interest

Postgraduate Institute for Medicine (PIM) requires faculty, planners, and others in control of educational content to disclose all their financial relationships with ineligible companies. All identified conflicts of interest (COI) are thoroughly vetted and mitigated according to PIM policy. PIM is committed to providing its learners with high quality accredited continuing education activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of an ineligible company.

The PIM planners and others have nothing to disclose. The OBG Project planners and others have nothing to disclose.

Faculty: Susan J. Gross, MD, receives consulting fees from Cradle Genomics, and has financial interest in The ObG Project, Inc.

Planners and Managers: The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

Method of Participation and Request for Credit

Fees for participating and receiving CME credit for this activity are as posted on The ObG Project website. During the period from March 4 2018 through 07/15/2022, participants must read the learning objectives and faculty disclosures and study the educational activity.

If you wish to receive acknowledgment for completing this activity, please complete the post-test and evaluation. Upon registering and successfully completing the post-test with a score of 100% and the activity evaluation, your certificate will be made available immediately.

For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service within 4 weeks.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and The ObG Project. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physician Continuing Medical Education

Postgraduate Institute for Medicine designates this enduring material for a maximum of 0.25 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 0.2 contact hours.

Read Disclaimer & Fine Print

BACKGROUND AND PURPOSE:

  • Studies report incidences from 0.2% to 1.6% of injury to lower urinary tract during gynecologic laparoscopy
  • Wong et al. (Obstetrics & Gynecology, 2018) examined the current urinary tract injury trends in gynecologic laparoscopy for benign indications

METHODS:

  • Systematic review and meta-analysis
  • Comprehensive literature review of 433 studies including
    • 90 studies published between 1975 and 2015
      • Total of 140,444 surgeries
    • All articles reporting the incidence of urinary tract injury in gynecologic laparoscopy for benign indication
  • Exclusion criteria comprised malignancy, surgery by urogynecologists, research not in English, and insufficient data
  • Causes of lower urinary tract injury included the following
    • Electrosurgery or laser ablation
    • Forceps or scissor use
    • Lysis of adhesions or dissection
    • Suturing or stapling
    • Vaginal surgery
    • Veress or trocar insertion
    • Unspecified cause
  • Outcomes of interest were findings that could help enhance patient counseling
    • Incidence, location, cause, timing, management, and long-term sequelae of lower urinary tract injury in gynecologic laparoscopy for benign indications

RESULTS:

  • 458 lower urinary tract injuries were reported with an incidence of 0.33% (95% CI 0.30–0.36)
  • Bladder injury (0.24%; 95% CI 0.22–0.27) was 3x more frequent than ureteral injury (0.08%; 95% CI 0.07–0.10)
  • The highest rates of injury were associated with laparoscopic hysterectomy not otherwise specified (1.8%; 95% CI 1.2–2.6) and laparoscopically assisted vaginal hysterectomy (1.0%; 95% CI 0.9–1.2)
  • Most ureteral injuries resulted from electrosurgery or laser ablation (33.3%; 95% CI 24.3–45.8)
  • Most bladder injuries resulted from lysis of adhesions or dissection (23.3%; 95% CI 18.7–29.0)
  • Ureteral injuries were most often
    • Recognized postoperatively (60%; 95% CI 47–76)
    • Repaired by open ureteral anastomosis (47.4%; 95% CI 36.3–61.9)
  • Bladder injuries were most often
    • Recognized intraoperatively (85%; 95% CI 75–95)
    • Repaired by laparoscopic suturing (34.9%; 95% CI 29.2–41.7)
  • No significant difference was found with use of cystoscopy (P=.28)
  • Without cystoscopy
    • 38% of ureteral injuries were recognized intraoperatively and 84% of bladder injuries
  • With routine cystoscopy
    • 53% of ureteral injuries were recognized intraoperatively and 94% of bladder injuries

CONCLUSION:

  • The likelihood of lower urinary tract injury during laparoscopy for benign conditions is 0.33%
  • Laparoscopic hysterectomy and vaginal hysterectomy are associated with the highest injury risk
  • The authors state that

Given the recent endorsement of routine cystoscopy by professional gynecologic societies and the incorporation of cystoscopy training into obstetrics and gynecology residency programs, it is likely that the ability of gynecologic surgeons to detect lower urinary tract injuries through cystoscopy will continue to improve and contribute to the promotion of universal cystoscopy.

Learn More – Primary Sources:

Urinary Tract Injury in Gynecologic Laparoscopy for Benign Indication: A Systematic Review

Take a post-test and get CME credits

TAKE THE POST TEST

Now You Can Get ObG Clinical Research Summaries Direct to Your Phone, with ObGFirst

ObGFirst® – Try It Free! »

image_pdfFavoriteLoadingFavorite

< Previous
All Grand Rounds Posts
Next >

Related ObG Topics:

Practical info for your gynecology practice
When to Consider Intraoperative Cystourethroscopy?
Best Method of Evaluating the Ureters When Indigo Carmine is Not Available?
Practical info for your gynecology practice
Surgery for Urinary Incontinence – When the Sling’s the Thing
Prolapse and Stress Incontinence: Burch Procedure vs Midurethral Sling

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

Are you an
ObG Insider?

Get specially curated clinical summaries delivered to your inbox every week for free

  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Already a Member of ObGFirst®?

Please log in to ObGFirst to access the 2T US Atlas

Password Trouble?

Not an ObGFirst® Member Yet?

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!
ObGFirst Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site